Vol. 22 No. 2 (2022): December 2022

Editorials

The place of Glucagon-like 1 peptide receptor agonists (GLP-1RAs) in the new NICE guidelines – what is going on?

Stephen C Bain

69-71
- PDF
- HTML
Why are GLP-1 receptor agonists in short supply?

Clifford J. Bailey

72
- PDF
- HTML

Reviews

Sodium-glucose co-transporter 2 inhibitors and erythrocytosis: a review

Najeeb Shah, Thushari Bandara, Harshal Deshmukh, Lucy Batten, Chris Walton, Thozhukat Sathyapalan

73-77
- PDF
- HTML
Intra-operative tissue sampling and microbiological analyses during minor lower limb amputations in patients with diabetes are poorly reported and difﬁcult to interpret

Mohamed Gulamhussein, Ridwaan Sohawon, Hannah Travers, Michael Wall

78-81
- PDF
- HTML

Original Research

Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the ﬁrst National Health Service (NHS) EndoBarrier service

Robert E Ryder, Mahi Yadagiri, Wyn Burbridge, Susan P Irwin, Hardeep Gandhi, Tahira Bashir, Rachael A Allden, Melanie Wyres, Melissa Cull, John P Bleasdale, Edward N Fogden, Mark R Anderson, Piya Sen Gupta

82-86
- PDF
- HTML

Learning from practice

Implementing the new NICE guidelines for type 2 diabetes (NG28): Focusing beyond HbA1c targets and clinically phenotyping patients to the appropriate second-line agent

Lakshminarayanan Varadhan, Ponnusamy Saravanan, Sarah Ali, Wasim Hanif, Vinod Patel

87-94
- PDF
- HTML

Current Topics

The use of HbA1c for new diagnosis of diabetes in those with hyperglycaemia on admission to or attendance at hospital urgently requires research

Susan Elisabeth Manley, Andreas Karwath, John Williams, Peter Nightingale, Jonathan Webber, Rajeev Raghavan, Alison Barratt, Craig Webster, Rachel Round, Irene Stratton, Georgios Gkoutos, Graham Roberts, Samiul Mostafa, Sandip Ghosh

95-104
- PDF
- HTML
Series: Cardiovascular outcome trials for diabetes drugs. Cardiovascular outcome trials with GLP-1 receptor agonists from exenatide and EXSCEL

Miles Fisher

105-111
- PDF
- HTML
The origins of type 2 diabetes medications

Clifford J Bailey

112-120
- PDF
- HTML

Short Communication

Liraglutide 3.0 (Saxenda) in bariatric patients: a retrospective real-world clinical evaluation of effectiveness

Amelia Simenacz, Rebekah Wilmington , Carol Green, Arash Ardavani , Iskandar Idris

121-124
- PDF
- HTML

Research Letter

Outcomes from day case surgery performed by one podiatric surgeon during the COVID-19 pandemic in patients from a multidisciplinary diabetic foot clinic

Jolyon Dales, Rajesh Jogia, Rachel Berrington, Deborah Modha, Marie-France Kong

125-126
- PDF
- HTML

Quality Improvement Winning Paper

Enhancing inpatient diabetes care by developing a new Capillary Blood Glucose and ketone monitoring chart: a Quality Improvement Project (QIP)

Kaenat Mulla, Suganya Giri Ravindran, Michele Cui, Simon Broadhurst, Laura Sharp, Zoe Bullock; Maggie Carroll, Chantal Kong

127-128
- PDF
- HTML
Use of a simpliﬁed local guideline improves “front door” management of diabetes and hyperglycaemia in people admitted to hospital with COVID-19

Elizabeth Fetherston, Su Tee, Mei Lan Kwok, Satish Artham, Peter Carey, Rahul Nayar, David Bishop, Ashwin Joshi

129-131
- PDF
- HTML
Sustaining improvement in diabetes-related ketoacidosis management through a Quality Improvement Projects

Lakshmi Narayanan Rengarajan, Katrina Nash, Emma Ooi, Catherine Cooper, Amy Birchenough, Megan Owen, Sanjay Saraf, Ali Karamat, Parijat De, Senthil Krishnasamy, Parth Narendran, Punith Kempegowda

132-138
- PDF
- HTML

The Rowan Hillson Insulin Safety Award

The Rowan Hillson Inpatient Safety Award 2022 The best interventions: redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID

Umesh Dashora, Punith Kempegowda, Adrian Li, Sophie Harris , Erwin Castro, Rowan Hillson, Christine Jones, Ketan Dhatariya

139-146
- PDF
- HTML

Meeting Reports

ABCD News

ABCD News

Dipesh Patel, Umesh Dashora, Rebecca Reeve, Alexandros Liarakos, Pratik Choudhary

152-162
- PDF
- HTML

Abstracts

Abstracts from ABCD Conference 7 - 8 September, 2022, NEC, Birmingham

Admin Two

163-169
- PDF
- HTML

Editorials

The place of Glucagon-like 1 peptide receptor agonists (GLP-1RAs) in the new NICE guidelines – what is going on?

Why are GLP-1 receptor agonists in short supply?

Reviews

Sodium-glucose co-transporter 2 inhibitors and erythrocytosis: a review

Intra-operative tissue sampling and microbiological analyses during minor lower limb amputations in patients with diabetes are poorly reported and difﬁcult to interpret

Original Research

Duodenal-jejunal bypass liner for treatment of T2DM and obesity: 4-year outcomes in the ﬁrst National Health Service (NHS) EndoBarrier service

Learning from practice

Implementing the new NICE guidelines for type 2 diabetes (NG28): Focusing beyond HbA1c targets and clinically phenotyping patients to the appropriate second-line agent

Current Topics

The use of HbA1c for new diagnosis of diabetes in those with hyperglycaemia on admission to or attendance at hospital urgently requires research

Series: Cardiovascular outcome trials for diabetes drugs. Cardiovascular outcome trials with GLP-1 receptor agonists from exenatide and EXSCEL

The origins of type 2 diabetes medications

Short Communication

Liraglutide 3.0 (Saxenda) in bariatric patients: a retrospective real-world clinical evaluation of effectiveness

Research Letter

Outcomes from day case surgery performed by one podiatric surgeon during the COVID-19 pandemic in patients from a multidisciplinary diabetic foot clinic

Quality Improvement Winning Paper

Enhancing inpatient diabetes care by developing a new Capillary Blood Glucose and ketone monitoring chart: a Quality Improvement Project (QIP)

Use of a simpliﬁed local guideline improves “front door” management of diabetes and hyperglycaemia in people admitted to hospital with COVID-19

Sustaining improvement in diabetes-related ketoacidosis management through a Quality Improvement Projects

The Rowan Hillson Insulin Safety Award

The Rowan Hillson Inpatient Safety Award 2022 The best interventions: redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID

Meeting Reports

Overview of the hybrid 82nd Scientific Sessions of the American Diabetes Association Dr Caroline Day reports on the New Orleans-based hybrid meeting, held on the 3rd-7th June, 2022

Impressions from EASD 2022 Dr Caroline Day reports on the European Association for the Study of Diabetes 58th annual meeting; aka Hybrid EASD 2022

Reflections from IDF 2022 Dr Caroline Day reports from the International Diabetes Federation World Diabetes Conference in Lisbon, Portugal (onsite and online), held 5th – 8th December, 2022

ABCD News

ABCD News

Abstracts

Abstracts from ABCD Conference 7 - 8 September, 2022, NEC, Birmingham